Evidence map›Paper›PMID 30561639›Full record

ArticleHuman molecular genetics2019

FOXF2 is required for cochlear development in humans and mice.

Guney Bademci, Clemer Abad, Armagan Incesulu, Fahed Elian, Azadeh Reyahi, Oscar Diaz-Horta, Filiz B Cengiz, Claire J Sineni, Serhat Seyhan, Emine Ikbal Atli and 13 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Review
  5. Article
  6. Mutations inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Breast cancer (Dove Medical Press) · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 4 countries.

Guney BademciJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Clemer AbadJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Armagan IncesuluDepartment of Otolaryngology-Head and Neck Surgery, Eskisehir Osmangazi University, Eskisehir, Turkey.
Fahed ElianDepartment of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Azadeh ReyahiDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Oscar Diaz-HortaJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Filiz B CengizJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Claire J SineniJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Serhat SeyhanJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Emine Ikbal AtliDepartment of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Hikmet BasmakDepartment of Ophthalmology, Eskisehir Osmangazi University, Eskisehir, Turkey.
Selma DemirDepartment of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Ali Moussavi NikDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Tim FootzDepartment of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Shengru GuoJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Duygu DumanDivision of Pediatric Genetics, Ankara University School of Medicine, Ankara, Turkey.
Suat FitozDepartment of Radiology, Ankara University School of Medicine, Ankara, Turkey.
Hakan GurkanDepartment of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Susan H BlantonJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Michael A WalterDepartment of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Peter CarlssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Katherina WalzJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Mustafa TekinJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Dr. John T. Macdonald Foundation · USUniversity of Miami · USTrakya University · TRUniversity of Alberta · CAUniversity of Gothenburg · SEAnkara University · TREskişehir Osmangazi University · TR

Funding

A Collaborative Search for New Genes for Non-Syndromic DeafnessR01DC009645 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MUSTAFA TEKIN · 2010 to 2026
$11.8M
Genetic Studies of Inner Ear AnomaliesR01DC012836 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TEKIN, MUSTAFA · 2013 to 2017
$3.2M
NIDCD NIH HHS R01 DC009645NIDCD NIH HHS R01 DC012836
6 · The paper itself

Abstract

Molecular mechanisms governing the development of the human cochlea remain largely unknown. Through genome sequencing, we identified a homozygous FOXF2 variant c.325A>T (p.I109F) in a child with profound sensorineural hearing loss (SNHL) associated with incomplete partition type I anomaly of the cochlea. This variant is not found in public databases or in over 1000 ethnicity-matched control individuals. I109 is a highly conserved residue in the forkhead box (Fox) domain of FOXF2, a member of the Fox protein family of transcription factors that regulate the expression of genes involved in embryogenic development as well as adult life. Our in vitro studies show that the half-life of mutant FOXF2 is reduced compared to that of wild type. Foxf2 is expressed in the cochlea of developing and adult mice. The mouse knockout of Foxf2 shows shortened and malformed cochleae, in addition to altered shape of hair cells with innervation and planar cell polarity defects. Expressions of Eya1 and Pax3, genes essential for cochlear development, are reduced in the cochleae of Foxf2 knockout mice. We conclude that FOXF2 plays a major role in cochlear development and its dysfunction leads to SNHL and developmental anomalies of the cochlea in humans and mice.

Indexed as

AdultAnimalsChildCochleaEmbryonic DevelopmentFemaleForkhead Transcription FactorsHair Cells, AuditoryHumansIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutNuclear ProteinsOrganogenesisEYA1 protein, humanForkhead Transcription FactorsFOXF2 protein, humanFoxf2 protein, mouseIntracellular Signaling Peptides and ProteinsNuclear ProteinsPAX3 protein, humanPAX3 Transcription FactorProtein Tyrosine Phosphatases

Identifiers

PMID30561639
PMCPMC6452198
OpenAlexW2903938051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.